@prefix np: . @prefix npx: . @prefix ns1: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { rdf:OBJECT rdfs:label "the importance of organ injury prevention in COVID-19" . rdf:OBJECT-POSITION rdfs:label "(24, 32)" . rdf:PREDICATE rdfs:label "highlighted" . rdf:PREDICATE-POSITION rdfs:label "66" . rdf:SUBJECT rdfs:label "The still-controversial efficacy of Dexamethasone and tocilizumab" . rdf:SUBJECT-POSITION rdfs:label "(24, 32)" . ns1:highlight ; rdfs:label "efficacy" . rdfs:label "covid-19" . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" . sub:assertion prov:generatedAtTime "2023-06-01T14:23:55.168963"^^xsd:dateTime . rdf:Statement rdfs:label "The still-controversial efficacy of Dexamethasone and tocilizumab highlighted the importance of organ injury prevention in COVID-19." . rdfs:ABSTRACT-UID rdfs:label "fp4chn9a" . rdfs:TRIPLE-UID rdfs:label "fp4chn9a-TRIPLE-ABSTRACT-4" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }